| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 05/13/2009 | EP2056803A2 Thiol-based agents for reducing toxicities associated with medical procedures employing radiographic contrast agents |
| 05/13/2009 | EP1856041B1 Crystallisation and purification of glycopyrronium bromide |
| 05/13/2009 | EP1721610B1 Composition containing benzamidine derivative and method for stabilizing benzamidine derivative |
| 05/13/2009 | EP1397356B1 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (pai-1) |
| 05/13/2009 | CN101428108A Preparation method of Chinese medicine formulation |
| 05/13/2009 | CN101428107A Process for producing osmanthus attached glutinous rehmannia formulation |
| 05/13/2009 | CN101428102A Process for producing medicine for treating prostatoplasia |
| 05/13/2009 | CN101428041A Cordyceps sinensis extract, preparation method and uses in preparing medicament |
| 05/13/2009 | CN101427774A Foods for improving and treating prostate and method of producing the same |
| 05/13/2009 | CN100486967C 5HT2C receptor modulators |
| 05/13/2009 | CN100486610C Shenkeshu capsule for treating chronic renal failure and its preparation technology |
| 05/13/2009 | CN100486576C Substituted pyridinones as modulators of P38MAP kinase |
| 05/13/2009 | CN100486573C Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and use |
| 05/13/2009 | CN100486570C Use of luciferin and derivatives in preparing medicine for treating live animal secretory diarrhea and inhibiting cyst growth |
| 05/12/2009 | US7531655 Large conductance calcium-activated K channel opener |
| 05/12/2009 | US7531625 Nucleotide sequences coding neuronal outgrowth and stability protein for use in treating ovarian, renal, neurological, cell proliferative and cardiovascular disorders |
| 05/12/2009 | US7531567 effector ambroxole with ACE inhibitors; treatment of a disturbance of the thiol-disulfide status in kidney replacement therapy |
| 05/12/2009 | US7531564 Substituted benzoxazoles as estrogenic agents |
| 05/12/2009 | US7531544 Xanthine phosphodiesterase V inhibitors |
| 05/12/2009 | US7531540 phosphodiesterase type 4 inhibitors; to treat respiratory disorders, skin disorders like psoriasis and atopic eczema; low toxicity, high bioavailability, no significant side effects; 2-{4-[(4aS,8aR)-4-(3,4-dimethoxyphenyl)-1-oxo-4a,5,8,8a-tetrahydro-1H-phthalazin-2-yl]-piperidin-1-yl}-acetamide |
| 05/12/2009 | US7531536 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 05/12/2009 | US7531532 Pyridine derivative and pyrimidine derivative |
| 05/12/2009 | US7531531 Method of treating diseases associated with altered kinase activity with bicyclo-pyrazoles |
| 05/12/2009 | US7531183 Biologically active hemagglutinin from type A Clostridium botulinum and methods of use |
| 05/12/2009 | CA2356080C Improved formulation for transportation of corticosteroid through pores of a barrier |
| 05/12/2009 | CA2264005C Piperazino derivatives as neurokinin antagonists |
| 05/07/2009 | WO2009058400A1 Compositions for tissue repair/regeneration |
| 05/07/2009 | WO2009057685A1 Pharmaceutical composition for treating overactive bladder |
| 05/07/2009 | WO2009057569A1 Film-coated preparation |
| 05/07/2009 | WO2009057165A1 Use of microvesicles (mvs) derived from stem cells for preparing a medicament for endo/epithelial regeneration of damaged or injured tissues or organs, and related in vitro and in vivo methods |
| 05/07/2009 | WO2009056582A1 Novel compounds |
| 05/07/2009 | WO2009056232A2 Combination of pde5 inhibitors with muscarinic receptor antagonists |
| 05/07/2009 | WO2009055933A1 Medium-chain length fatty acids and glycerides as nephroprotection agents |
| 05/07/2009 | WO2009055857A1 Calcium-rich alkaline powder produced from processed molluse shells |
| 05/07/2009 | WO2009009727A3 Ghrh analogs and therapeutic uses thereof |
| 05/07/2009 | US20090118469 High-Affinity Antagonists of ELR-CXC Chemokines |
| 05/07/2009 | US20090118334 Method of treatment of cardiac and/or renal failure using a calcium channel blocker and an angiotensin converting enzyme inhibitor or an angiotensin ii receptor blocker |
| 05/07/2009 | US20090118281 Amino Alcohol Derivatives And Their Use As Renin Inhibitor |
| 05/07/2009 | US20090118182 Fibroblast Growth Factor-Like Polypeptides |
| 05/07/2009 | US20090118163 Factor H for the Treatment of Chronic Nephropathies and Production thereof |
| 05/07/2009 | US20090117159 Pharmaceutical compositions comprising fesoterodine |
| 05/07/2009 | US20090117133 POLYMERIC IMMUNOGLOBULIN FUSION PROTEINS THAT TARGET LOW AFFINITY FCyRECEPTORS |
| 05/07/2009 | CA2704627A1 Compositions for tissue repair/regeneration |
| 05/07/2009 | CA2704298A1 Pharmaceutical composition for treating overactive bladder |
| 05/07/2009 | CA2704286A1 Medium-chain length fatty acids and glycerides as nephroprotection agents |
| 05/07/2009 | CA2704248A1 Calcium-rich alkaline powder produced from processed mollusc shells |
| 05/06/2009 | EP2055301A1 Solid oral dosage forms comprising valsartan |
| 05/06/2009 | EP2054374A1 Novel hydrate form of o-desmethyl venlafaxine succinate |
| 05/06/2009 | EP1807065A4 Methods and compositions for treating nephrogenic diabetes insipidus |
| 05/06/2009 | EP1443961B1 Glycoprotein compositions |
| 05/06/2009 | EP1414525B1 2-(3,5-bis-trifluoromethyl-phenyl)-n-¬6-(1,1-dioxo-1.lambda.6-thiomorpholin-4-yl)-4-(2-methyl or 4-fluoro-2-methyl substituted)phenyl-pyridin-3-yl -n-methyl-isobutyramide |
| 05/06/2009 | EP1308440B1 Piperidine derivatives and drugs containing these derivatives as the active ingredient |
| 05/06/2009 | CN101426792A Pyrazolopyrimidines as therapeutic agents |
| 05/06/2009 | CN101426763A Sulfide and disulfide compounds and compositions for cholesterol management and related uses |
| 05/06/2009 | CN101426501A The use of beta-aminoalcohols for the treatment of inflammatory disorders and pain |
| 05/06/2009 | CN101423500A Substituted benzoxazoles and analogues as estrogenic agents |
| 05/06/2009 | CN101422614A Methods of treating lupus based on antibody affinity and screening methods and compositions for use thereof |
| 05/06/2009 | CN101422576A Traditional Chinese medicine oral liquid for treating poultry kidney injury |
| 05/06/2009 | CN101422546A Functional food for treating male prostatitis |
| 05/06/2009 | CN100484934C Processes for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinase |
| 05/06/2009 | CN100484933C Novel pyrazine compounds, their use in preparing medicament for treating diseases correlated with serotonin |
| 05/06/2009 | CN100484569C Medicament for mobilizing pluripotent stem cells from tissue into peripheral blood |
| 05/05/2009 | US7528252 Derivatives of triazoly-imidazopyridine useful as ligands of the adenosine A2a receptor and their use as medicaments |
| 05/05/2009 | US7528231 Kv10.1, a novel voltage-gated potassium channel from human brain |
| 05/05/2009 | US7528152 synthetic analog of Hemiasterlin; anticarcinogenic agent; restenosis of blood vessels subject to traumas such as angioplasty and stenting; safe and effective, while retaining stability in biological media; exhibit low cytotoxicity to non-dividing normal cells |
| 05/05/2009 | US7528110 Anti-allergic complex molecules |
| 05/05/2009 | US7527974 Preparing embryonic stem cells via nuclear transplantation; tissue engineering and the use of embryonic stem in diagnosis, prevention and treatment of cell proliferative, nervous system, muscular and bone disorders; tissue repair |
| 04/30/2009 | WO2009055351A1 Methods of treating urogenital-neurological disorders using modified clostridial toxins |
| 04/30/2009 | WO2009054483A1 Drug containing salusin-β |
| 04/30/2009 | WO2009054468A1 Azolecarboxamide compound or salt thereof |
| 04/30/2009 | WO2009054454A1 Regulator for signaling of toll-like receptor, which comprises cathepsin inhibitor as active ingredient |
| 04/30/2009 | WO2009054150A1 Tetrapyrrole derivative, and use thereof for medical purposes |
| 04/30/2009 | WO2009053857A2 Management and treatment of benign prostatic hyperplasia |
| 04/30/2009 | WO2009053842A2 Prevention of recurrence of urethral stricture after a conventional treatment |
| 04/30/2009 | WO2009052972A2 Use of norgestimate as a selective inhibitor of trpc3, trpc6 and trpc7 ion channels |
| 04/30/2009 | WO2009052630A1 Compositions and methods for treating fibroproliferative disorders |
| 04/30/2009 | WO2009032885A3 Piperidinylamino-thieno[2,3-d] pyrimidine compounds for treating fibrosis |
| 04/30/2009 | WO2007014327A3 Small compounds that correct protein misfolding and uses thereof |
| 04/30/2009 | WO2004092199A3 Method for identifying modulators of g protein coupled receptor signaling |
| 04/30/2009 | US20090110677 Polypeptide regulating phosphate metabolism, calcium metabolism, calcification and vitamin d metabolism and dnas encoding the same |
| 04/30/2009 | CA2704100A1 Compositions and methods for treating fibroproliferative disorders |
| 04/30/2009 | CA2703370A1 Methods of treating urogenital-neurological disorders using modified clostridial toxins |
| 04/30/2009 | CA2703106A1 Azolecarboxamide derivatives as trka inhibitors |
| 04/30/2009 | CA2702510A1 Use of norgestimate as a selective inhibitor of trpc3, trpc6 and trpc7 ion channels |
| 04/29/2009 | EP2053041A2 1,3,5-Trisubstituted 2(1H)-pyridones as AMPA receptor inhibitors useful for the treatment of eg Parkinson's disease |
| 04/29/2009 | EP2053038A1 Aminoalcohol derivative and immunosuppressant containing the same as an active ingredient |
| 04/29/2009 | EP2052724A1 Use of norgestimate as a selective inhibitor of TRPC3, TRPC6 and TRPC6 and TRPC7 ion channel |
| 04/29/2009 | EP2051967A1 Benzimidazole derivatives useful in treatment of vallinoid receptor trpv1 related disorders |
| 04/29/2009 | EP1874130A4 Methods and compositions for the prevention and treatment of kidney disease |
| 04/29/2009 | EP1416937B1 Prophylactic and therapeutic use of hydroxysteroids |
| 04/29/2009 | EP1218509B1 Fibroblast growth factor-like polypeptides |
| 04/29/2009 | EP1066286B1 Heterocyclo-substituted imidazopyrazine protein tyrosine kinase inhibitors |
| 04/29/2009 | CN101420958A Co-administration of adenosine A1 receptor antagonists and anticonvulsants |
| 04/29/2009 | CN101420946A Tamsulosin-containing percutaneous absorption type preparation |
| 04/29/2009 | CN101420933A Paediatric amino acid solution for parenteral nutrition |
| 04/29/2009 | CN101418033A Method for synthesizing finasteride |
| 04/29/2009 | CN101417971A Indolines compounds, preparation method and pharmaceutical application thereof |
| 04/29/2009 | CN101417129A Gabapentin analogues for fibromyalgia and other related disorders |
| 04/29/2009 | CN101417109A Medicine for treating bed-wetting and urinary incontinence |
| 04/29/2009 | CN101417103A Traditional Chinese medicine formulation for treating hyperplasia prostate |